Merck & Co., Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2025: USD 25.19

Merck & Co., Inc. Revenue Per Share is USD 25.19 for the Trailing 12 Months (TTM) ending March 31, 2025, a 4.22% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
  • Merck & Co., Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 24.17, a 5.84% change year over year.
  • Merck & Co., Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 22.83, a 7.00% change year over year.
  • Merck & Co., Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 21.34, a 24.33% change year over year.
  • Merck & Co., Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 17.16, a -9.15% change year over year.
Key Data
Date Revenue Per Share Free Cash Flow Per Share Dividend Per Share Debt to Equity Ratio